View all Oncology Briefing CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.

Accreditation/ Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


PER Pulse™ Recaps highlight key elements of the Oncology Briefings: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors online CME activity.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Daiichi Sankyo, Inc.

Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors

Release Date: April 28, 2017
Expiration Date: April 28, 2018
Media: Internet - based


Activity Overview

The Oncology Briefings™ is an online interactive monograph that will include an overview of the pathophysiology of tenosynovial giant cell tumors (TGCT) in addition to a review of recent data regarding treatments in patients with TGCT, designed to aid physicians in applying those findings to their practices. Commentary by a thought leader, key take-home points, and pearls for practice will place the content into perspective.

CME Activity Table of Contents

  • Background of TGCT
  • Current Treatment Approaches for TGCT
  • Emerging Treatment Approaches for TGCT
  • Importance of Multidisciplinary Team and Patient Counseling

Instructions for This Activity and Receiving Credit

  • You will need to login to participate in the activity.
  • This activity contains an interactive question(s). You may move forward through the activity; however, you may not go back to change answers or review content until you finish the activity.
  • At the end of the activity, an “Educational Content” link will be available for you to download content in PDF format for your reference.
  • If you close the Web browser after you complete the activity, the “Educational Content” link will disappear, and you will need to review the activity in its entirety to once again access the link to the educational content.
  • In order to receive a CME certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational initiative is directed toward medical oncologists, surgeons, rheumatologists, and hematologists who treat patients with TGCT. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of such malignancies will also be invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  1. Identify recent advancements in the understanding of TGCT pathogenesis
  2. Evaluate current clinical trial efficacy and safety data of novel pharmacologic therapies for TGCT
  3. Develop evidence-based treatment plans for the various forms of TGCT
  4. Describe the role of multidisciplinary management as a best practice to optimize outcomes for patients with TGCT

Faculty, Staff, and Planners' Disclosures


William D. Tap, MD
Chief, Sarcoma Medical Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosure: Consultant: Daiichi Sankyo and Plexxikon.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical and nursing education purposes only, and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER®.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
2 Clarke Drive
Suite 110
Cranbury, NJ 08512

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)

  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Minimum System Requirements (Mac OS)

  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Calendar of Events
Filter By